StopDown
Zenex Animal Health logo
Company

Zenex Animal Health

Animal health makerzenexah.com ↗LinkedIn ↗

Zenex Animal Health revenue, valuation and funding

Zenex Animal Health reported revenue of ₹1,023 crore in FY25 (the year to March 2025), against ₹823.6 crore in FY24, per filings and statements as reported.

Zenex Animal Health revenue, valuation and funding
Revenue (FY25)₹1,023 crore
Revenue (FY24)₹823.6 crore
Net profit (FY24)₹14.9 crore

Figures from filings and statements as reported; the table below carries each year with its source.

Zenex Animal Health key facts

₹2,921 crorePrice paid for the Zydus animal health business2021
$52.5 millionIFC and Emerging Asia Fund stake purchaseDec 2021
₹1,023 croreFY25 revenueFY25 Profile

Zenex Animal Health revenue and profit by year

Zenex Animal Health revenue and profit by financial year, ₹ crore, from filings and statements as reported
YearRevenueProfit or lossExpensesNoteSource
FY25₹1,023 crorelatest financials as reported by VCCircle and Inc42 DataLabs; profit left out because the two sources differ slightly (₹26.2 crore and ₹26.4 crore) VCCircleInc42 DataLabs
FY24₹823.6 crore₹14.9 croreprior-year figures given by VCCircle VCCircle

As reported for each financial year; where sources disagree the figure is left out rather than picked.

Funding rounds

Zenex Animal Health funding rounds, as announced
WhenRoundAmountInvestorsSource
Dec 2021Secondary stake purchaseUp to $52.5 millionIFC (about $16M), Emerging Asia Fund (about $36.5M); sellers: Multiples Private Equity Fund III VCCircle

Timeline

  • FY25 FY25 results: revenue about ₹1,023 crore, up from ₹823.6 crore VCCircle
  • 2021
  • May 2021 Multiples-led consortium agrees to buy the animal health business of a Zydus Cadila unit for ₹2,921 crore through Zenex Animal Health India Medical Dialogues
  • Dec 2021 IFC and Emerging Asia Fund propose to buy up to $52.5 million of shares from Multiples Private Equity Fund III VCCircle
  • 2023
  • Dec 2023 Acquires Ayurvet, a herbal animal care company; price not disclosed VCCircle
  • 2025
  • Dec 2025 Nitendra Patel joins as chief human resources officer Economic Times HRWorld
  • 2026
  • Feb 2026 Buys a majority stake in Dutch firm VievePharm; price not disclosed Mint
  • Apr 2026 Aniruddha Rajurkar named chief executive Indian Pharma Post
  • Sep 2026 Buys SAVAVET, the pet care unit of SAVA Healthcare; price not disclosed Moneycontrol

The short version

  • Zenex Animal Health makes veterinary medicines and nutrition products for livestock, poultry and pets. MoneycontrolVCCircle
  • It began when a consortium led by Multiples Alternate Asset Management, with CPP Investments and RARE Enterprises, agreed in 2021 to buy the animal health business of a Zydus Cadila unit for ₹2,921 crore. Medical Dialogues
  • The business had about 700 employees and one factory in Haridwar when the deal was announced. Medical Dialogues
  • In December 2021 IFC and its Emerging Asia Fund proposed to buy up to $52.5 million of shares from Multiples Private Equity Fund III. VCCircle
  • It bought herbal animal care firm Ayurvet in December 2023, Dutch natural nutrition maker VievePharm (majority stake) in February 2026 and the SAVAVET pet care business of SAVA Healthcare in September 2026; prices were not disclosed. VCCircleMintMoneycontrol
  • Aniruddha Rajurkar became chief executive in April 2026, and Nitendra Patel joined as chief human resources officer in December 2025. Indian Pharma PostEconomic Times HRWorld

Deals and partnerships

Zenex Animal Health deals and partnerships, as announced
WhenWithWhatPriceSource
May 2021Zydus Animal Health and Investments (India animal health business)Animal health medicines, with a plant in Haridwar₹2,921 crore Medical Dialogues
Dec 2023AyurvetHerbal products for livestock, poultry and petsUndisclosed VCCircle
Feb 2026VievePharmDutch natural animal nutrition products; majority stakeUndisclosed Mint
Sep 2026SAVAVETPet care business of SAVA HealthcareUndisclosed Moneycontrol

Products

  • Livestock, poultry and pet medicines: Veterinary medicines and nutrition products, with brands added through its acquisitions. VCCircleMoneycontrol
  • Natural animal nutrition: Herbal products from Ayurvet and bolus (slow-release tablet) products for minerals, vitamins and udder health from VievePharm. VCCircleMint

People

  • Aniruddha Rajurkar: Chief executive since April 2026; earlier chief executive of SAVA Healthcare and Shield Healthcare and head of Dr. Reddy's India business. Indian Pharma Post
  • Nitendra Patel: Chief human resources officer since December 2025; earlier chief human resources officer at Symphony. Economic Times HRWorld

Questions people ask about Zenex Animal Health

Who owns Zenex Animal Health?

Zenex is backed by Multiples Alternate Asset Management, whose consortium bought the business in 2021 with CPP Investments and RARE Enterprises. In December 2021 IFC and its Emerging Asia Fund proposed to buy up to $52.5 million of shares from Multiples Private Equity Fund III. Current stakes were not found. Medical DialoguesVCCircle

What does Zenex Animal Health do?

Zenex makes veterinary medicines and nutrition products for livestock, poultry and pets. It started with the animal health business of a Zydus Cadila unit, which had a plant at Haridwar, and has since added Ayurvet, VievePharm and SAVAVET through acquisitions. Medical DialoguesVCCircleMintMoneycontrol

How much did Zenex pay for the Zydus animal health business?

The consortium behind Zenex agreed to pay ₹2,921 crore in a cash-free, debt-free slump sale, reported in May 2021. It was expected to close within 90 days, and a LinkedIn company profile gives July 2021 for the close. The business had about 700 employees. Medical Dialogues

Who is the CEO of Zenex Animal Health?

Aniruddha Rajurkar was named chief executive in April 2026. He earlier ran SAVA Healthcare and Shield Healthcare as chief executive and led Dr. Reddy's India business. Indian Pharma Post

What is Zenex Animal Health's revenue?

Zenex Animal Health reported revenue of about ₹1,023 crore in its latest financials, FY25, up from ₹823.6 crore a year earlier, according to VCCircle and Inc42 DataLabs. Its profit is small, around ₹26 crore, but the two sources differ by a little, so no exact figure is given. No FY26 figure has been reported. VCCircleInc42 DataLabs

Every line links to the article it came from, written in our own words. Not investment advice. Profile updated 2026-11-14.

Stories cover its acquisition, people and funding news. Sectors: Healthcare & Life Sciences. Stages: Growth equity. Based in Ahmedabad. Stories run from 6 December 2021 to 30 September 2026.

Who put in money

Up against

Boehringer IngelheimElancoZoetisAlltechBayer

Every story on Zenex Animal Health

For Zenex Animal Health: add the “Featured on StopDown” badge

Put this on your website's press or media page. It links readers to Zenex Animal Health on StopDown.

Featured on StopDownFeatured on StopDown, dark

· About the badge